Hyperbaric oxygen therapy (HBOT) has been used as treatment for different clinical conditions, including fibromyalgia (FM). HBOT modulates brain activity, ameliorates chronic pain and modifies the ratio of immune cells. Clinical studies have provided evidence that FM is associated with immune system dysregulation. In the present study we aimed to evaluate the effect of HBOT on immune system and on the quality of life-style of FM patients.
Guggino, G., Schinocca, C., Lo Pizzo, M., Di Liberto, D., Garbo, D., Raimondo, S., et al. (2019). T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 37 Suppl 116(1), 81-89.
T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy
Guggino, Giuliana
;Schinocca, Claudia;Lo Pizzo, Marianna;Di Liberto, Diana;Garbo, Domenico;Raimondo, Stefania;Alessandro, Riccardo;Brighina, Filippo;Sireci, Guido;Triolo, Giovanni;Dieli, Francesco
2019-01-01
Abstract
Hyperbaric oxygen therapy (HBOT) has been used as treatment for different clinical conditions, including fibromyalgia (FM). HBOT modulates brain activity, ameliorates chronic pain and modifies the ratio of immune cells. Clinical studies have provided evidence that FM is associated with immune system dysregulation. In the present study we aimed to evaluate the effect of HBOT on immune system and on the quality of life-style of FM patients.
| File | Dimensione | Formato | |
|---|---|---|---|
|
article.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
1.6 MB
Formato
Adobe PDF
|
1.6 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
